Earn Recurring Revenue Helping Clients Solve Their Biggest Drug-Cost Problem.
GLP-1 and specialty drugs are the fastest-growing cost line in every self-funded plan you advise. ColdRxMeds cuts that spend 30–70% — and pays you a recurring revenue share for every client you introduce, for the life of the account.
A solution your clients need. An income stream you keep.
You already have the relationships. We already have the program — proven at $5M+ in annual volume with full compliance documentation on every order.
Recurring, Not One-Time
Your revenue share is paid on program volume for the life of the account — not a one-time finder’s fee. As your client’s program grows, so does your commission. One strong introduction can produce income for years.
Zero Servicing Burden
ColdRxMeds handles the savings analysis, compliance documentation, member enrollment, pharmacist review, cold-chain fulfillment, and monthly reporting. You make the introduction. We do everything else.
A Compliance Story That Holds
Manitoba IPS licensing, DIN-to-NDC matching, 19-field dispensing records, and 7-year retention give you a program you can put in front of any CFO, legal team, or stop-loss carrier with confidence.
Four steps. One introduction. Recurring income.
The partnership is deliberately simple — your role ends where our operational lift begins.
You introduce
Identify a client with meaningful GLP-1 or specialty drug spend — a self-insured employer, TPA, or health plan — and make a warm introduction. That’s the extent of your lift.
We run the numbers
We deliver a free savings analysis within 48 hours — drug by drug, methodology documented, ready to present to a CFO or board. No commitment required, no data burden on you.
We implement and service
ColdRxMeds handles compliance review, program design, member enrollment, pharmacist oversight, cold-chain fulfillment, and monthly savings reporting. Your client gets white-glove service under your relationship umbrella.
You earn — for the life of the account
A recurring share of program revenue is paid to you for as long as the client remains active. The commission structure is straightforward and discussed in one conversation.
One introduction can be worth six figures a year.
Specialty drug programs scale — and your commission scales with them.
The math that matters
A single mid-size TPA or employer group can generate millions in annual program volume. Your recurring revenue share on an account of that size is a meaningful, durable income stream — earned from one warm introduction. Our largest partner relationship currently exceeds $5M in annual volume. We’ll walk you through the exact commission structure in one conversation, no obligation.
Who makes a strong referral
Self-insured employers with 100+ members on GLP-1s or specialty injectables. TPAs looking for a documented cost-containment story at renewal. Health plans and cost containment firms facing specialty trend they can’t control. If your client’s pharmacy spend keeps coming up in renewal conversations — they’re a fit.
You’re lending us your credibility. We take that seriously.
Every referral reflects on you. Here’s what your name is attached to when you introduce ColdRxMeds.
- Brand-name only — sourced from the original manufacturer’s supply chain. No compounded GLP-1s, no generics substitution, ever.
- Manitoba IPS-licensed sourcing — the only Canadian province authorized for international Rx fulfillment.
- Cold-chain validated — every temperature-sensitive order ships 2–8°C in validated packaging with mandatory tracking.
- Audit-ready documentation — 19-field dispensing records on every order, retained seven years, available to plan sponsors on request.
- Voluntary member opt-in — no mandates, no formulary disruption, no changes to the existing PBM or TPA relationship.
Let’s talk. One conversation, no obligation.
We’ll walk you through the program, the compliance package, and the commission structure — and answer every question your clients will ask you.
Your cart
-
Sorry !! No Medication found, Please find your Medications here